血液系统恶性肿瘤治疗耐受性评估方法的应用进展
Progress in Application of Evaluation Methods of Treatment Tolerance for Hematological Malignancies
黄斯漫 1万超玲 1吴德沛 1薛胜利1
作者信息
- 1. 国家血液系统疾病临床医学研究中心,江苏省血液研究所,苏州大学附属第一医院,国家卫生健康委员会血栓与止血重点实验室,江苏苏州 215006
- 折叠
摘要
血液系统恶性肿瘤在循证医学的实践下已有了规范诊疗流程和合适治疗方案推荐,然而由于疾病的异质性和人群个体差异,不同患者在同一方案治疗下所取得的临床疗效及治疗相关毒副作用不尽相同.如何准确预测血液系统恶性肿瘤个体对特定治疗方案的耐受性至关重要.全文就血液系统恶性肿瘤患者的治疗耐受性评估方法进行综述,以便临床工作者为不同患者作出耐受性科学评估并协助制定最佳治疗方案.
Abstract
Although standardized diagnosis and treatment procedures and appropriate therapy have been recommended for hematological malignancies under the practice of evidence-based medicine,due to heterogeneity of the disease and individual differences in the population,different patients may get dif-ferent clinical efficacy and treatment-related toxicities under the same therapy.How to predict the toler-ance of an individual with hematological malignancy to a specific regimen accurately is critical.This pa-per reviews the evaluation methods of treatment tolerance in patients with hematological malignancies,assisting clinicians in making scientific evaluation of tolerance for different patients and choosing the most suitable regimen.
关键词
血液系统恶性肿瘤/治疗/耐受性/评估方法Key words
hematological malignancies/treatment/tolerance/evaluation methods引用本文复制引用
出版年
2025
NETL
NSTL
万方数据